Literature DB >> 17082653

Major basic protein homolog (MBP2): a specific human eosinophil marker.

Douglas A Plager1, David A Loegering, James L Checkel, Junger Tang, Gail M Kephart, Patricia L Caffes, Cheryl R Adolphson, Lyo E Ohnuki, Gerald J Gleich.   

Abstract

Human eosinophil granule major basic protein (MBP1) is an exceedingly basic (isoelectric point >11) 14-kDa protein, comprising the core of the secondary eosinophil granule. Recently, a less cationic homolog of MBP, termed MBPH or simply, MBP2, has been discovered. We prepared a panel of mAbs to MBP2 and used these Abs to localize and quantitate this molecule in leukocytes and biological fluids. Specific mAbs for MBP2 were selected using slot-blot analyses and used in a two-site immunoassay, Western blotting, and immunofluorescence microscopy. The sensitivity of the immunoassay was markedly improved by reduction and alkylation of MBP2. MBP1 is more abundant than MBP2 in lysates of eosinophils and their granules, as judged by immunoassay and Western blotting. By immunofluorescence, MBP1 is present in eosinophils, basophils, and a human mast cell line (HMC1), whereas MBP2 is only detected in eosinophils. Neither MBP1 nor MBP2 could be detected in any other peripheral blood leukocyte. MBP2 levels measured in plasma and serum were essentially identical. In contrast to past measurements for MBP1, MBP2 was not detected above normal levels in sera from pregnant donors. However, measurement of serum MBP2 discriminated patients with elevated eosinophils from normal subjects, and MBP2 was also detectable in other biological specimens, such as bronchoalveolar lavage, sputum, and stool. These results indicate that MBP2 is present only in eosinophils and that it may be a useful biomarker for eosinophil-associated diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17082653     DOI: 10.4049/jimmunol.177.10.7340

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Anti-inflammatory effects of the R2 peptide, an inhibitor of transglutaminase 2, in a mouse model of allergic asthma, induced by ovalbumin.

Authors:  Dae Yong Kim; Bum Soo Park; Gwan Ui Hong; Byung Jae Lee; Jung Won Park; Soo Youl Kim; Jai Youl Ro
Journal:  Br J Pharmacol       Date:  2011-01       Impact factor: 8.739

Review 2.  Refining the definition of hypereosinophilic syndrome.

Authors:  Hans-Uwe Simon; Marc E Rothenberg; Bruce S Bochner; Peter F Weller; Andrew J Wardlaw; Michael E Wechsler; Lanny J Rosenwasser; Florence Roufosse; Gerald J Gleich; Amy D Klion
Journal:  J Allergy Clin Immunol       Date:  2010-07       Impact factor: 10.793

Review 3.  Biology of the eosinophil.

Authors:  Carine Blanchard; Marc E Rothenberg
Journal:  Adv Immunol       Date:  2009       Impact factor: 3.543

4.  Mycobacterium bovis-BCG vaccination induces specific pulmonary transcriptome biosignatures in mice.

Authors:  Elihu Aranday Cortes; Daryan Kaveh; Javier Nunez-Garcia; Philip J Hogarth; H Martin Vordermeier
Journal:  PLoS One       Date:  2010-06-28       Impact factor: 3.240

5.  Eosinophil ribonucleases and their cutaneous lesion-forming activity.

Authors:  Douglas A Plager; Mark D P Davis; Amy G Andrews; Michael J Coenen; Terry J George; Gerald J Gleich; Kristin M Leiferman
Journal:  J Immunol       Date:  2009-08-28       Impact factor: 5.422

6.  Development of a suspension array assay in multiplex for the simultaneous measurement of serum levels of four eosinophil granule proteins.

Authors:  Michelle A Makiya; Jesica A Herrick; Paneez Khoury; Calman P Prussin; Thomas B Nutman; Amy D Klion
Journal:  J Immunol Methods       Date:  2014-06-08       Impact factor: 2.303

7.  Development and application of novel immunoassays for eosinophil granule major basic proteins to evaluate eosinophilia and myeloproliferative disorders.

Authors:  Diane L Squillace; James L Checkel; Ayalew Tefferi; Hirohito Kita; Gerald J Gleich
Journal:  J Immunol Methods       Date:  2021-03-06       Impact factor: 2.287

8.  Altered esophageal histamine receptor expression in Eosinophilic Esophagitis (EoE): implications on disease pathogenesis.

Authors:  Jamie Merves; Prasanna Modayur Chandramouleeswaran; Alain J Benitez; Amanda B Muir; Anna J Lee; Diana M Lim; Kara Dods; Isha Mehta; Eduardo D Ruchelli; Hiroshi Nakagawa; Jonathan M Spergel; Mei-Lun Wang
Journal:  PLoS One       Date:  2015-02-27       Impact factor: 3.240

9.  A functional gammadeltaTCR/CD3 complex distinct from gammadeltaT cells is expressed by human eosinophils.

Authors:  Fanny Legrand; Virginie Driss; Gaëtane Woerly; Sylvie Loiseau; Emmanuel Hermann; Jean-Jacques Fournié; Laurent Héliot; Virginie Mattot; Fabrice Soncin; Marie-Lise Gougeon; David Dombrowicz; Monique Capron
Journal:  PLoS One       Date:  2009-06-17       Impact factor: 3.240

Review 10.  Tropical pulmonary eosinophilia--a review.

Authors:  Jai B Mullerpattan; Zarir F Udwadia; Farokh E Udwadia
Journal:  Indian J Med Res       Date:  2013-09       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.